BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27881396)

  • 1. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT; Maeshima A; Kayakabe K; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F297-F304. PubMed ID: 27881396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
    Front Immunol; 2021; 12():584414. PubMed ID: 33717066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
    Lema GP; Maier H; Nieto E; Vielhauer V; Luckow B; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2001 Jul; 12(7):1369-1382. PubMed ID: 11423566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/
    Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
    J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
    J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.
    Iwata Y; Boström EA; Menke J; Rabacal WA; Morel L; Wada T; Kelley VR
    J Immunol; 2012 May; 188(9):4568-80. PubMed ID: 22467656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
    Boswell JM; Yui MA; Burt DW; Kelley VE
    J Immunol; 1988 Nov; 141(9):3050-4. PubMed ID: 3262676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C; Zhao ML; Scearce RM; Diaz M
    Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G; Lucio-Cazaña FJ; Molina A; Luckow B; Schmid H; de Wit C; Moreno-Manzano V; Banas B; Mampaso F; Schlöndorff D
    Kidney Int; 2004 Sep; 66(3):1018-28. PubMed ID: 15327395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
    Gonzalo-Gil E; García-Herrero C; Toldos O; Usategui A; Criado G; Pérez-Yagüe S; Barber DF; Pablos JL; Galindo M
    Front Immunol; 2018; 9():1948. PubMed ID: 30210500
    [No Abstract]   [Full Text] [Related]  

  • 17. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Tan H; Zhao J; Wang S; Zhang L; Wang H; Huang B; Liang Y; Yu X; Yang N
    Int Immunopharmacol; 2012 Dec; 14(4):401-9. PubMed ID: 22922317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
    Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
    J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
    Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
    Nowling TK; Rodgers J; Thiyagarajan T; Wolf B; Bruner E; Sundararaj K; Molano I; Gilkeson G
    PLoS One; 2020; 15(3):e0230499. PubMed ID: 32187230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.